Bristol-Myers Squibb's top products based on revenue 2015-2018

Bristol-Myers Squibb is a multinational pharmaceutical company headquartered in New York City. As of 2018, their top products included Opdivo, a drug used in the treatment of certain cancers, and Eliquis, an anticoagulant. Those drugs generated 6.7 and 6.4 billion dollars in revenue for the company, respectively. Other top drugs for the company included Orencia, Sprycel and Yervoy, to name a few.

Bristol-Myers Squibb’s company profile

Bristol-Myers Squibb (BMS) is a pharmaceutical company that produces pharmaceuticals and biologics in several therapeutic areas. BMS has experienced increasing revenues, especially among their prioritized brand areas. Despite increasing revenues, the company’s net income has remained variable over time.

The global oncology market

The global oncology market has grown significantly in recent years, with new therapies being added every year. Bristol-Myers Squibb (BMS) was ranked third among the top pharmaceutical companies based on their global oncology market share. Other top pharmaceutical companies include Roche and Celgene. The top oncology products world-wide based on market share include Keytruda, Revlimid, and Opdivo, which are marketed by Merck, Celgene, and BMS respectively.

Bristol-Myers Squibb's top products based on revenue from 2015 to 2018

Drug name (therapy area)2015201620172018
-----
-----
-----
-----
-----
-----
-----
-----
-----
-----
Exclusive Premium statistic

You need a Premium Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Premium Account

only $59 / month *
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$708 / Year

Show detailed source information?
Register for free
Already a member?
Log in
Source

Release date

February 2019

Region

Worldwide

Survey time period

2015 to 2018

Supplementary notes

Figures for 2015 were quoted from the previous annual report.
* Franchise, total revenues.

Open this statistic in...
Statista Accounts: Access All Statistics. Starting from $708 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account!

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$59 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.

Statistics on "Oncology"

Statista Accounts: Access All Statistics. Starting from $708 / Year
Learn more about how Statista can support your business.